The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APOGEE THERAPEUTICS INC | COM | 03770N101 | BBG01H51WYQ5 | 76,537,452 | 2,048,647 | SH | SOLE | 2,048,647 | 0 | 0 | ||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | BBG000QSGWX5 | 18,979,049 | 3,554,129 | SH | SOLE | 3,554,129 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | BBG00B6G7GL7 | 95,073,977 | 815,176 | SH | SOLE | 815,176 | 0 | 0 | ||
| BICARA THERAPEUTICS INC | COM | 055477103 | BBG00Z15DGK7 | 10,217,735 | 784,170 | SH | SOLE | 784,170 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | BBG007DHZQR7 | 37,291,590 | 6,225,641 | SH | SOLE | 6,225,641 | 0 | 0 | ||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | BBG00FB2NPZ0 | 48,990,535 | 2,700,691 | SH | SOLE | 2,700,691 | 0 | 0 | ||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | BBG00CP3BDD4 | 63,031,065 | 3,202,798 | SH | SOLE | 3,202,798 | 0 | 0 | ||
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | BBG005TP2339 | 13,413,750 | 6,125,000 | SH | SOLE | 6,125,000 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | BBG00KT2KFX7 | 24,480,928 | 1,102,248 | SH | SOLE | 1,102,248 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | BBG00Z1SLMK5 | 51,598,768 | 727,563 | SH | SOLE | 727,563 | 0 | 0 | ||
| ORUKA THERAPEUTICS INC | COM | 687604108 | BBG000BWNN28 | 34,595,920 | 3,371,922 | SH | SOLE | 3,371,922 | 0 | 0 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | BBG00KT2RRM6 | 44,175,097 | 1,374,031 | SH | SOLE | 1,374,031 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | BBG0067L94B2 | 64,832,060 | 4,018,101 | SH | SOLE | 4,018,101 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG002H242Z5 | 46,449,559 | 3,445,813 | SH | SOLE | 3,445,813 | 0 | 0 | ||
| ZENAS BIOPHARMA INC | COM | 98937L105 | BBG01J1MG9D6 | 14,953,167 | 1,892,806 | SH | SOLE | 1,892,806 | 0 | 0 | ||